The global immunotherapy drugs market is undergoing a transformative phase, driven by innovative treatments and growing demand for personalized medicine. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of 10.5% over the forecast period of 2022-2028. With a revenue of approximately USD 209 billion in 2022, the market is anticipated...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian